New Insights on the Role of Milk Products in the Prevention of Type 2 Diabetes


Eleven million Canadians are living with diabetes or prediabetes. Roughly 90% of people living with diabetes have type 2 diabetes (T2D). 

There is currently a global epidemic of type 2 diabetes. Growing evidence suggests a protective role of dairy products in diabetes risk. The relationship between dairy consumption and type 2 diabetes has been examined in a number of studies including several meta-analyses. The totality of the evidence to date indicates that dairy, including higher fat milk products, as well as yogurt and cheese specifically, are associated with a reduced risk of developing type 2 diabetes.

By the end of the webinar, participants will:

  • Have a better understanding of the role of milk products in the prevention of type 2 diabetes;
  • Learn about new and emerging evidence on the role of milk products in the prevention of type 2 diabetes; and,
  • Get insights that can be applied in their daily practice.

Key topics addressed:

  • Prevalence of type 2 diabetes (T2D), especially in Canada
  • Risk factors in the development of T2D
  • Scientific evidence on the role of milk products in the prevention of T2D
  • Potential mechanisms related to milk products in the prevention of T2D
  • New and emerging evidence: dairy fatty acids, fermented dairy foods

After watching the webcast, to receive your certificate of attendance, you can simply send an email to

Anthony Hanley, PhD


Department of Nutritional Sciences
University of Toronto

Dr. Hanley received his PhD in Epidemiology in 2000 from the University of Toronto. He subsequently completed a postdoctoral fellowship at the University of Texas Health Sciences Centre in San Antonio. From 2002-2005, Dr. Hanley was a Research Scientist at the Leadership Sinai Centre for Diabetes at Mt. Sinai Hospital, Toronto. Since 2005, Dr. Hanley has been a faculty member in the Department of Nutritional Sciences, University of Toronto, where he teaches, conducts research, and supervises graduate students. His research is supported by the Canadian Institutes for Health Research, Dairy Farmers of Canada, and the University of Toronto Banting and Best Diabetes Centre.

Dr. Hanley’s research interests include the metabolic and nutritional epidemiology of type 2 diabetes and its underlying physiological traits, including obesity, insulin resistance and pancreatic beta cell dysfunction. His work focuses on longitudinal cohorts of understudied high-risk populations, including Indigenous Canadians, those of African and Hispanic origin, and non-diabetic subjects who are otherwise at very high risk of progression to diabetes, including those with pre-diabetes or the metabolic syndrome. For over 25 years, Dr. Hanley has had the privilege of working closely with Indigenous partners to address the heavy burden of type 2 diabetes in that population using a variety of approaches.